Prometa Pharmacotherapy for Methamphetamine Dependence

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Drug AbuseDrug Dependence
Interventions
DRUG

Prometa

Medication protocol includes 2 infusion periods of 3 and 2 days, respectively and outpatient medications for 39 days

DRUG

Placebo

Placebo protocol includes 2 infusion periods of 3 and 2 days, respectively and outpatient placebo medications for 39 days.

Trial Locations (1)

90025

UCLA Integrated Substance Abuse Programs, Los Angeles

All Listed Sponsors
lead

University of California, Los Angeles

OTHER

NCT00260481 - Prometa Pharmacotherapy for Methamphetamine Dependence | Biotech Hunter | Biotech Hunter